A comparison of the effect of vitamin A on cytokine secretion by mononuclear cells of preterm newborns and adults

Neonatology

Volumn 91, Issue 3, 2007, Pages 196-202

  Bessler, H ^a   Wyshelesky, G ^a   Osovsky, M ^b,c   Prober, V ^a   Sirota, L ^b,c  

^a RABIN MEDICAL CENTER   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cytokines; Mononuclear cells; Preterm newborns; Vitamin A

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; RETINOL PALMITATE;

ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HUMAN; HUMAN CELL; MALE; NEWBORN; PERIPHERAL BLOOD MONONUCLEAR CELL; PREMATURITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UMBILICAL CORD BLOOD;

ADULT; BRONCHOPULMONARY DYSPLASIA; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; TREATMENT OUTCOME; VITAMIN A;

EID: 33947592935     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000097453     Document Type: Article

References (46)

1. Mangelsdorf DJ, Umensono K, Evans RM: The retinoid receptors; in Sporn MB, Roberts BS, Goodman DS (eds): The Retinoids: Biology, Chemistry and Medicine. New York, Raven Press, 1994, pp 319-349.
2. Kastner P, Mark M, Chambon P: Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 1995;83:859-869.
3. Chambon P: A decade of molecular biology of retinoic acid receptor. FASEB J 1996;10:940-954.
4. Semba RD: Vitamin A as anti-infective therapy. J Nutr 1999;129:783-791.
5. Semba RD: Vitamin A, immunity, and infection. Clin Infect Dis 1994;19:489-499.
6. Semba RD, Lyles CM, Margolick JB, Caiaffa WT, Farzadegan H, Cohn S, Vlahov D: Vitamin A supplementation and human immunodeficiency virus load in infection drug users. J Infect Dis 1998;177:611-616.
7. Edelman R, Suskind R, Oslon RE, Sirisinha S: Mechanisms of defective delayed cutaneous hypersensitivity in children with protein-calorie malnutrition. Lancet 1973;1:506-508.
8. Smythe PM, Brereton-Stiles GG, Grace HJ, Mafoyane A, Schonland M, Coovadia HM, Loening WE, Parent MA, Vos GH: Thymolymphatic deficiency and depression of cell mediated immunity in protein-calorie malnutrition. Lancet 1971;2:939-943.
9. Ross AC: Vitamin A deficiency and retinoid repletion regulate the antibody response to bacterial antigen and the maintenance of natural killer cells. Clin Immunol Immunopathol 1996;80:S63-S72.
10. Kilic SS, Kezer EY, Ilcol YO, Yakut T, Aydin S, Ulus IH: Vitamin A deficiency in patients with common variable immunodeficiency. J Clin Immunol 2005;25:275-280.
11. Jason J, Archibald LK, Nwanyanwu OC, Sowell AL, Buchanan I, Larned J, Bell M, Kazembe PN, Dobbie H, Jarvis WR: Vitamin A level and immunity in humans. Clin Diagn Lab Immunol 2002;9:616-621.
12. Biesalski HK, Nohr D: Importance of vitamin-A for lung function and development. Mol Aspects Med 2003;24:431-440.
13. Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA, Stoll BJ, Lemons JA, Stevenson DK, Bauer CR, Korones SB, Fanaroff AA: Vitamin A supplementation for extremely low birth weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 1999;340:1962-1968.
14. Baier RJ, Majid A, Parupia H, Loggins J, Kruger TE: CC Chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia. Pediatr Pulmonol 2004;37:137-148.
15. Darlow BA, Graham PJ: Vitamin A supplementation for preventing morbidity and mortality in very low birth infants. Cochrane Database Syst Rev 2002;(4):CD000501.
16. Heidelise ALS: Neurobehavioral development of the preterm infant;in Fanaroff AA, Martin RJ (eds): Neonatal-Perinatal Medicine. Diseases of the Fetus and Infants. St Louis, Mosby, 1997, vol 2, pp 964-991.
17. De Bont ES, de Leij LH, Okken A, Baarsma R, Kimpen YL: Increased plasma concentrations of interleukin-1 receptor antagonist in neonatal sepsis. Pediatr Res 1995;37:626-689.
18. McCall CE, Grosso-Wilmoth LM, LaRue K, Guzman RN, Cousart SL: Tolerance to endotoxin-induced expression of the interleukin-1 gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 1993;91:853-861.
19. Fisher CJ Jr, Opal SM, Lowry SF, Sadoff JC, LaBrecque JF, Donovan HC, Lookabaugh JL, Lemke J, Pribble JP, Stromatt SC: Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsis. Circ Shock 1994;44:1-8.
20. Gardlund B, Sjolin J, Nilsson A, Roll M, Wickerts CY, Wretlind B: Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis 1995;172:296-301.
21. Goldie AS, Fearon KC, Ross JA, Barclay GR, Jackson RE, Grant IS, Ramsay G, Blyth AS, Howie JC: Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Investigation Group. JAMA 1995;274:172-177.
22. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-2147.
23. Arend WP: Interleukin 1 receptor antagonist. Adv Immunol 1993;54:167-227.
24. Chikanza IC, Roux LP, Dayer JM, Panayi GS: Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathologic implications. Arthritis Rheum 1995;38:642-648.
25. Kristensen M, Deleuan B, Eedy DJ, Breathnach SM, Brennan FM: Distribution of interleukin-1 receptor antagonist protein (IRAP), interleukin-1 receptor, and interleukin-1 alpha in normal and psoriatic skin. Decreased expression of IRAP in psoriatic patients. Br J Dermatol 1992;127:305-311.
26. Hayashi S, Hashimoto S, Kitamura N, Hanazawa S, Horie T: Retinoic acid regulates differentially the expression of IL-1β and IL-1 receptor antagonist (IL-1ra) in PMA-activated human monocytes. Biochem Biophys Res Commun 1996;224:574-578.
27. Hashimoto S, Hayashi S, Yoshida S, Kujime K, Maruoka S, Matsumoto K, Gon Y, Koura Y, Horie T: Retinoic acid differentially regulate interleukin-1β and interleukin-1 receptor antagonist production by human alveolar macrophages. Leukemia Res 1998;22:1057-1061.
28. Sirota L, Punsky I, Bessler H: Effect of indomethacin on IL-1, IL-6 and TNF production by mononuclear cells of preterm newborns and adults. Acta Paediatr 2000;89:331-335.
29. Sirota L, Schacham D, Punsky I, Bessler H: Ibuprofen affects pro- and anti-inflammatory cytokine production by mononuclear cells of preterm newborns. Biol Neonate 2001;79:103-108.
30. Tucci A, Mouzaki A, James H, Bonnefoy JY, Zubler RH: Are cord blood B cells functionally mature? Clin Exp Immunol 1991;84:389-394.
31. Taylor S, Bryson YJ: Impaired production of gamma-interferon by newborn cells in vitro is due to a functionally immature macrophage. J Immunol 1985;134:1493-1497.
32. Hunt DW, Huppertz HI, Jiang HJ, Petty RE: Studies of human cord blood dendritic cells: Evidence for functional immaturity. Blood 1994;84:4333-4343.
33. Kavelaars A, Zijlstra J, Bakker JM, Van Rees EP, Visser A, Zegers BJM, Heijnen CJ: Increased dexamethasone sensitivity of neonatal leukocytes: different mechanisms of glucocorticoid inhibition of T cell proliferation in adult and neonatal cells. Eur J Immunol 1995;25:1346-1351.
34. Bessler H, Straussberg R, Gurary N, Aloni D, Sirota L: Effect of dexamethasone on IL-2 and IL-3 production by mononuclear cells of neonates and adults. Arch Dis Child Fetal Neonatal Ed 1996;75:F197-F201.
35. Blomhoff HK: Vitamin A regulates proliferation and apoptosis of human T- and B-cells. Biochem Soc Trans 2004;32:982-984.
36. Jiang XL, Everson MP, Lamon EW: A mechanism of retinoid potentiation of murine Tcell responses: early upregulation of interleukin-2 receptors. Int J Immunopharmacol 1993;15:309-317.
37. Garbe A, Buck J, Hammerling U: Retinoids are important cofactors in T cell activation. J Exp Med 1992;176:109-117.
38. Engedal KN, Ertesvag A, Blomhoff HK: Survival of activated human T lymphocytes is promoted by retinoic acid via induction of IL-2. Int Immunol 2004;16:443-453.
39. Blomhoff HK, Smeland EB, Erikstein B, Rasmussen AM, Skrede B, Skionsbeg C, Blomhoff R: Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells. Biol Chem 1992;267:23988-23992.
40. Fahlman C, Jacobsen SE, Smeland EB, Lomo J, Naess CE, Funderud S, Blomhoff HK: All-trans-and 9-cis-retinoic acid inhibit growth of normal human and murine B cell precursors. J Immunol 1995;155: 58-65.
41. Naderi S, Blomhoff HK: Retinoic acid prevents phosphorylation of pRB in normal human B lymphocytes: regulation of cyclin E, cyclin A, and p21(Cip1). Blood 1999;94:1348-1358.
42. Cantorna MT, Nashold FE, Hayes CE: In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. J Immunol 1994;152: 1515-1521.
43. Cui D, Moldoveanu Z, Stephensen CB: High level dietary vitamin A enhances T-helper type 2 cytokine production and secretory of immunoglobulin a response to influenza A virus in BALB/c mice. J Nutr 2000;130:1132-1139.
44. Wei LN: Retinoid receptors and their coregulators. Annu Rev Pharmacol Toxicol 2003;43:47-72.
45. Balmer JE, Blomhoff R: Gene expression regulation by retinoic acid. J Lipid Res 2002;43:1773-1808.
46. Lomo J, Smeland EB, Ulven S, Natarajan V, Blomhoff R, Gandhi U, Dawson MI, Blomhoff HK: RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes. J Cell Physiol 1998;175:68-77.